Lippincott Williams & Wilkins

SHERPA: Unknown

People

  1. Raj
    Raj
  2. Bodei
    Bodei
  3. O'Reilly
    O'Reilly
  4. Tang
    Tang
  5. Capanu
    Capanu
  6. Chou
    Chou
  7. Basturk
    Basturk
  8. Iacobuzio-Donahue
    Iacobuzio-Donahue
  9. Saltz
    Saltz
  10. Untch
    Untch

Groups

  1. Center for Pancreatic Cancer Research (71)
  2. Department of Medicine (67)
  3. Solid Tumor Oncology Division (60)
  4. Gastrointestinal Oncology Service (59)
  5. Hematology-Oncology Fellows (27)
  6. Weinberg Fellows (27)
  7. Department of Pathology and Laboratory Medicine (26)
  8. Sloan Kettering Institute Postdocs (26)
  9. Radiology, Department of (23)
  10. Surgery (20)
Search Within
  1. "Pancreas"
Formats
  1. Meeting Abstract (73)
  2. Journal Article (40)
  3. Review (3)
  4. Guidelines (2)
  5. Correspondence (1)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (71)
  2. Department of Medicine (67)
  3. Solid Tumor Oncology Division (60)
  4. Gastrointestinal Oncology Service (59)
  5. Hematology-Oncology Fellows (27)
  6. Weinberg Fellows (27)

More Groups

People
  1. Diane Reidy (43)
  2. Nitya Raj (27)
  3. David Klimstra (21)
  4. Lisa Bodei (16)
  5. Eileen O'Reilly (13)
  6. Laura Tang (12)

More People

Years
  1. 2024 (5)
  2. 2022 (11)
  3. 2021 (10)
  4. 2020 (9)
  5. 2019 (10)
  6. 2018 (15)

More Years

Publications
  1. Pancreas (121)

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of pembrolizumab-based therapy in previously treated extrapulmonary poorly-differentiated neuroendocrine carcinomas: Results of part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Hope, T. A.; Kolli, K. P.; Zhang, L.; Fattah, D.; Calabrese, S.; Grabowsky, J. A.; Perez, K.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results From the phase 3 SPINET study
    Meeting Abstract

    Reidy-Lagunes, D.; Hörsch, D.; Singh, S.; Caplin, M. E.; Ferone, D.; Wolin, E. M.; Capdevila, J.; Buikhuisen, W.; Raderer, M.; Dansin, E.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms (NENs) treated in the "modern era": A multicenter retrospective review
    Meeting Abstract

    Le, B. K.; McGarrah, P. W.; Whitman, J.; Paciorek, A.; Raj, N.; Reidy-Lagunes, D.; Hauser, H.; Le, T.; Del Rivero, J.; Apolo, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Methylation-based cell-free DNA signature for early detection of pancreatic cancer
    Journal Article

    Ying, L.; Sharma, A.; Chhoda, A.; Ruzgar, N.; Hasan, N.; Kwak, R.; Wolfgang, C. L.; Wang, T. H.; Kunstman, J. W.; Salem, R. R.; more...
    Pancreas (2021)

    Fulltext@MSK | Save
  • Early detection of pancreatic cancer: Applying artificial intelligence to electronic health records
    Review

    Kenner, B. J.; Abrams, N. D.; Chari, S. T.; Field, B. F.; Goldberg, A. E.; Hoos, W. A.; Klimstra, D. S.; Rothschild, L. J.; Srivastava, S.; Young, M. R.; more...
    Pancreas (2021)

    Fulltext@MSK | Save
  • POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
    Meeting Abstract

    Kindler, H. L.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J.; Hochhauser, D.; Oh, D.; more...
    Pancreas (2021)

    Fulltext@MSK | Save
  • POLQ knockout induces synthetic lethality in HR-deficient pancreatic cancer
    Meeting Abstract

    Oh, G.; Wang, A.; Wang, L.; Li, J.; Zhao, E.; Werba, G.; Wan, S.; Sfeir, A.; Simeone, D. M.
    Pancreas (2021)

    Fulltext@MSK | Save